Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
ABCA4 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
Invitae Macular Dystrophy Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 66 | 36 |
|
Retinitis pigmentosa 19, 601718; RP19 (Retinitis pigmentosa) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Inherited Retinal Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 486 | 293 |
|
Invitae Comprehensive Carrier Screen Labcorp Genetics (formerly Invitae) LabCorp United States | 886 | 547 |
|
Stargardt Disease (STGD) and Macular Dystrophies Panel PreventionGenetics, part of Exact Sciences United States | 35 | 28 |
|
PreventionGenetics, part of Exact Sciences United States | 91 | 82 |
|
Autosomal Recessive Retinitis Pigmentosa (RP) Panel PreventionGenetics, part of Exact Sciences United States | 62 | 60 |
|
Amsterdam UMC Genome Diagnostics Amsterdam University Medical Center Netherlands | 4 | 1 |
|
ABCA4 Deletion/Duplication Analysis (Prenatal Diagnosis) Baylor Genetics United States | 4 | 1 |
|
ABCA4 Deletion/Duplication Analysis Baylor Genetics United States | 4 | 1 |
|
ABCA4 Comprehensive - Sequence & Deletion/Duplication Analysis Baylor Genetics United States | 4 | 1 |
|
Stargardt disease, Fundus Flavimaculatus or Retinal Dystrophy, Early-Onset Severe via the ABCA4 Gene PreventionGenetics, part of Exact Sciences United States | 4 | 1 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 4 | 1 |
|
Retinopathy and Optic Atrophy NGS Panel Fulgent Genetics United States | 563 | 241 |
|
Fulgent Genetics United States | 28 | 14 |
|
Fulgent Genetics United States | 4 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Retinitis Pigmentosa NGS Panel Fulgent Genetics United States | 329 | 124 |
|
Macular Degeneration NGS Panel Fulgent Genetics United States | 53 | 19 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.